Emmanuel Macron, President of the Republic of France

Welcome Message 2017

In today’s connected and interdependent world, health threats must be tackled globally. An integrated approach must be taken. This global approach to health is one of the G20’s key priorities.

The Sustainable Development Goals adopted as part of the 2030 Agenda for Sustainable Development of the United Nations are aimed at every country in the world in a global, partner-based and universal approach. Goal 3 on Health, in particular, aims to stamp out the epidemics of AIDS, tuberculosis, malaria and other communicable diseases and to effectively fight non-communicable diseases by 2030. The objective is to ultimately provide universal health coverage, with access to safe, efficient, affordable vaccines and medicines. To make this happen, it is essential to support the research and development of new vaccines.

The resurgence in resistance to antibiotics, which the World Health Organization, the G20 and the European Union see as an absolute priority, has proven that we must never stop being vigilant. To this end, France has joined forces with Germany to create a global R&D platform on antibiotic resistance. This must be carried forward in an integrated, systemic and unified approach. We must link environmental, public and animal health at local, national and global levels based on the concept of “One Health”. France committed to this at the G20 in Hamburg and the Franco-German Council of Ministers in Paris. I want priority to be given to developing new medicines, but also to R&D for new methods of diagnosis.

Personalized medicine and global health must receive an integrated response, involving medicine, biology, food, urbanization, environment and education. To achieve this, cooperation between states, the scientific, economic and medical stakeholders, and civil society is essential and must be planned over the long term. The World Health Summit has become a key forum for addressing these issues in a cross-cutting manner by bringing together these actors on an international level.

The terms of globality and universality are now more than ever associated with health:

  • international preventive measures;
  • quality care for all, accessible to all;
  • renewed support for health as a driver of development, growth and stability;
  • and an ambitious research policy, which is a source of progress.

These are principles to which France is committed, and which it supports in international bodies.

As patron of this Summit, I would like to join with the Chancellor of the Federal Republic of Germany and the President of the European Commission in wishing you all an excellent and productive meeting.